ArticleTranslational andrology and urology2026
Bioinformatics analysis and experimental validation confirm COL6A3 as a promising target for renal cell carcinoma therapy.
Zheng Qin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.